Zobrazeno 1 - 10 of 45 pro vyhledávání: '"A. S. Varlamov"'
1
Akademický článek
INFORMATIONAL AND COMMUNICATIONAL TECHNOLOGIES IN THE TRAINING OF BACHELORS OF EDUCATION IN THE SAFETY OF LIFE FIELD
Autor: Y. V. Egorova, E. M. Ruban, A. S. Varlamov
Publikováno v: Вестник Мининского университета, Vol 0, Iss 4 (2017)
The questions of informational and communicational technologies' application in the undergraduate education in the field of safety of life in the modern socio-cultural situation by means of electronic educational complex on discipline "Safety" are di
Externí odkaz: https://doaj.org/article/147b712746924c9dbf1b9e897f4bfc26
Zobrazit plný text záznamu
2
Akademický článek
History of Development Parametric Array in Air and Possibility of Their Application in Problems of Protection of the Information
Autor: O. S. Varlamov
Publikováno v: Безопасность информационных технологий, Vol 18, Iss 2, Pp 97-102 (2011)
Stages of development parametric array in air are considered, examples of possible use in systems of safety of the information are resulted.
Externí odkaz: https://doaj.org/article/fa75e3b6189c4749a60a88609792cc54
Zobrazit plný text záznamu
6
Building a decision support system based on fuzzy logic to reduce the total harmful emissions from a fossil fuel boiler or power plant
Autor: L I Filinkov, A M Likhter, A V Rybakov, K S Varlamov
Publikováno v: Journal of Physics: Conference Series. 2091:012056
This article discusses the software implementation using the theory of fuzzy sets. To build the model, we use data on wind direction, wind strength, the distance of residential buildings and the population of the expected area of pollution distributi
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::30b0b1cbac645f20a87ee1f0ab52ad77
https://doi.org/10.1088/1742-6596/2091/1/012056
Zobrazit plný text záznamu
7
Five-year overall survival of metastatic renal cell carcinoma patients treated with everolimus after progression on bevacizumab: a prospective multicenter study CRAD001LRU02T
Autor: S. Z. Safina, S. A. Varlamov, A. V. Snegovoy, I. S. Varlamov, L. I. Gurina, L. V. Manzuk, I. V. Tsimafeyeu
Publikováno v: Onkourologiâ, Vol 13, Iss 4, Pp 40-44 (2018)
Background. In a CRAD001LRU02T study of everolimus for metastatic renal cell carcinoma patients previously treated with bevacizumab ± interferon, median overall survival (OS) was 17.4 months (95 % confidence interval 13.5–21.3 month).Objective of
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e656392851e81fd9b068863b6ae6b3c4
https://doi.org/10.17650/1726-9776-2017-13-4-40-44
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje